1-4 of 4
Baiyong Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)

Amer M. Zeidan, Hongyan Tong, Zhijian Xiao, Praneeth Baratam, Ramzi Abboud, Christopher B. Benton, Joshua F Zeidner, Uma Borate, Wanxing Chai-Ho, Yonglin Lu, Jie Yang, Mingxiu Hu, Baiyong Li, Michelle Xia, David Sallman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6705.
https://doi.org/10.1182/blood-2024-200541
Published: 2024
Journal Articles

AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine for Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS): AK117-103 Phase 1b Results

Miao Miao, Qingliang Teng, Depei Wu, Zhongxing Jiang, Songfu Jiang, Fei Li, Yang Liang, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 1865.
https://doi.org/10.1182/blood-2023-179099
Published: 2023
Journal Articles

A Phase 1b Study Evaluating the Safety and Efficacy of AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine in Patients with Treatment-Naïve Acute Myeloid Leukemia

Huafeng Wang, Qike Zhang, Qingliang Teng, Zhenyu Li, Hong Liu, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4280.
https://doi.org/10.1182/blood-2023-180618
Published: 2023
Journal Articles

Population Pharmacokinetic Modeling and Exposure-Response Analysis Providing a Basis for Selecting Penpulimab Dose in a Population with Relapsed/Refractory Classic Hodgkin's Lymphoma

Benchao Chen, Xiaopin Jin, Yongcheng Dong, Max Wang, Dennis Xia, Michelle Xia, Baiyong Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4354.
https://doi.org/10.1182/blood-2021-151750
Published: 2021